Buy Full Version
"Morphine Market"

Let us help you !

Invalid Email.

Please Select Country.

Invalid contact no.

Special Symbols Not Allowed.

Invalid Security Code.

Thank You For Your Interest.

We've Successfully Got Your Message,

Our Executive will get back to you Shortly.

Morphine Market by Type (Oral Tablets, Injection, Capsule, and Others) By Application (Anesthesia, Cough Suppressant, and Diarrhea Suppressant) - Global Opportunity and Forecast, 2019-2026

Pharmaceuticals	LI_183654	Pages: NA	Jan 2020 \| 1784 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Morphine is an analgesic and narcotic drug obtained from opium for treatment of moderate to severe pain. As per the International Narcotics Control Board, 92 % of the worlds morphine is consumed by 17% of the worlds population, while the rest of the world population consumes around 8% of morphine.

The growth of the market for is driven by factors such as lifestyle changes that lead to pain and growth in number of surgical procedures as the drug is prescribed for pain relief post-surgery. However, the addictive nature of the drug restricts the growth of the global morphine market.

The report segments the medical crutches market on the basis of type, application, and geography. Based on type, the market is segmented into oral tablets, injection, capsule, and others. By application, it is classified into anesthesia, cough suppressant, and diarrhea suppressant. Geographical breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of the major market players such as Mallinckrodt Pharmaceuticals, Alcaliber SA, Purdue Pharma L.P, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries Ltd., Qinghai Pharmaceutical Co. Ltd., Northeast Pharmaceutical Group Co., Ltd., and others are provided in this report.

Key Benefits

This report provides an extensive analysis of the current and emerging market trends and dynamics in the global morphine market.
In-depth analysis has been done in this report by constructing market estimations for the key market segments between 2017 and 2023.
This study evaluating the competitive landscape and value chain has been taken into account to understand the competitive environment across the geographies.
This report entails the detailed quantitative analysis of the current trends and future estimations for 2017 to 2023, which assists to identify the prevailing market opportunities.
Comprehensive analysis of factors that drive and restrict the growth of the global morphine market is provided.
Exhaustive analysis of the global morphine market by product helps to understand the types of morphine commercially available for the treatment of pain.

Morphine Market Key Segments:

By Type

Oral Tablets
Injection
Capsule
Others

By Application

Anesthesia
Cough Suppressant
Diarrhea Suppressant

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- France
- Germany
- UK
- Italy
- Spain
- The Netherlands
- Norway
- Russia
- Sweden
- Switzerland
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- New Zealand
- Taiwan
- Thailand
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Chile
- Columbia
- Egypt
- Iran
- Israel
- Turkey
- Venezuela
- Rest of LAMEA

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS

3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities

CHAPTER 4 MORPHINE MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ORAL TABLETS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. INJECTION

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CAPSULE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. OTHERS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 MORPHINE MARKET, BY APPLICATION

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ANESTHESIA

5.2.1. Market size and forecast

5.3. COUGH SUPPRESSANT

5.3.1. Market size and forecast

5.4. DIARRHEA SUPPRESSANT

5.4.1. Market size and forecast

CHAPTER 6 MORPHINE MARKET, BY GEOGRAPHY

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Morphine Market by Type
6.2.5. North America Morphine Market by Application

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. The Netherlands market size and forecast
6.3.3.7. Norway market size and forecast
6.3.3.8. Russia market size and forecast
6.3.3.9. Sweden market size and forecast
6.3.3.10. Switzerland market size and forecast
6.3.3.11. Rest of Europe market size and forecast

6.3.4. Europe Morphine Market by Type
6.3.5. Europe Morphine Market by Application

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Taiwan market size and forecast
6.4.3.7. New Zealand market size and forecast
6.4.3.8. Thailand market size and forecast
6.4.3.9. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Morphine Market by Type
6.4.5. Asia-Pacific Morphine Market by Application

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Chile market size and forecast
6.5.3.3. Saudi Arabia market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Columbia market size and forecast
6.5.3.6. Egypt market size and forecast
6.5.3.7. Iran market size and forecast
6.5.3.8. Israel market size and forecast
6.5.3.9. Venezuela market size and forecast
6.5.3.10. Turkey market size and forecast
6.5.3.11. Rest of LAMEA market size and forecast

6.5.4. LAMEA Morphine Market by Type
6.5.5. LAMEA Morphine Market by Application

CHAPTER 7 COMPANY PROFILES

7.1. MALLINCKRODT PHARMACEUTICALS

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. ALCALIBER SA

7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments

7.3. PURDUE PHARMA L.P

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. SANOFI WINTHROP INDUSTRIE

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. MACFARLAN SMITH

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.6. SUN PHARMACEUTICAL INDUSTRIES LTD.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. QINGHAI PHARMACEUTICAL CO. LTD.

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. NORTHEAST PHARMACEUTICAL GROUP CO., LTD

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,041 Data Pack/Excel ~~$3,840~~ $3,379 Single User License ~~$5,370~~ $4,726 Five User License ~~$6,450~~ $5,676 Enterprise User License ~~$8,995~~ $7,916

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com